EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer’s disease

Anne Mette G Jensen, Jan Raska, Petr Fojtik, Giulia Monti, Melanie Lunding, Simona Bartova, Veronika Pospisilova iD, Sven J van der Lee, Jasper Van Dongen, Liene Bossaerts, Christine Van Broeckhoven iD, Oriol Dols-Icardo und 9 weitere

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2408262121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Anne Mette G Jensen und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Aarhus University, Aarhus C DK8000, Denmark. Hauptthemen laut MEDLINE: Alzheimer Disease, Endosomes, LDL-Receptor Related Proteins, Membrane Transport Proteins. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ZonMw (Netherlands Organisation for Health Research and Development), Health-Holland, Novo Nordisk Fonden (NNF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Truncating genetic variants of SORL1 , encoding the endosome recycling receptor SORLA, have been accepted as causal of Alzheimer’s disease (AD). However, most genetic variants observed in SORL1 are missense variants, for which it is complicated to determine the pathogenicity level because carriers come from pedigrees too small to be informative for penetrance estimations. Here, we describe three unrelated families in which the SORL1 coding missense variant rs772677709, that leads to a p.Y1816C substitution, segregates with Alzheimer’s disease. Further, we investigate the effect of SORLA p.Y1816C on receptor maturation, cellular localization, and trafficking in cell-based assays. Under physiological circumstances, SORLA dimerizes within the endosome, allowing retromer-dependent trafficking from the endosome to the cell surface, where the luminal part is shed into the extracellular space (sSORLA). Our results showed that the p.Y1816C mutant impairs SORLA homodimerization in the endosome, leading to decreased trafficking to the cell surface and less sSORLA shedding. These trafficking defects of the mutant receptor can be rescued by the expression of the SORLA 3Fn-minireceptor. Finally, we find that iPSC-derived neurons with the engineered p.Y1816C mutation have enlarged endosomes, a defining cytopathology of AD. Our studies provide genetic as well as functional evidence that the SORL1 p.Y1816C variant is causal for AD. The partial penetrance of the mutation suggests this mutation should be considered in clinical genetic screening of multiplex early-onset AD families.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseEndosomesLDL-Receptor Related ProteinsMembrane Transport ProteinsPedigreeHumansFemaleMaleMutation, MissenseProtein TransportProtein MultimerizationAgedMiddle AgedHEK293 Cells

Stichwörter der Autor:innen

3Fn-domainSORL1-associated Alzheimer’s diseaseSORLAdimerizationretromer

Substanzen

SORL1 protein, humanLDL-Receptor Related ProteinsMembrane Transport Proteins

Autor:innen und Institutionen

  • Department of Biomedicine, Aarhus University, Aarhus C DK8000, Denmark.
  • Department of Histology and Embryology, Faculty of Medicine, Brno 62500, Czech Republic.
  • International Clinical Research Center, St. Anne's Faculty Hospital Brno 60200, Brno, Czech Republic.
  • Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam University Medical Center 1081 HV, Amsterdam, The Netherlands.
  • Complex Genetics of Alzheimer's Disease Group, Vlaams Instituut voor Biotechnologie (VIB) Center for Molecular Neurology, VIB 2000, Antwerp, Belgium.
  • Department of Biomedical Sciences, University of Antwerp 2000, Antwerp, Belgium.

ORCID-Profile: Veronika Pospisilova, Christine Van Broeckhoven, Sonia Bellini, Roberta Ghidoni, Gregory A Petsko, Olav M Andersen

Förderung

  • ZonMw (Netherlands Organisation for Health Research and Development)
  • Health-Holland
  • Novo Nordisk Fonden (NNF)
  • Alzheimer's Association (AA)
  • Independent Research Fund Denmark
  • Czech Research Council
  • MEYS
  • Rainwater Charitable Foundation (RCF)

Zitieren

APA

Jensen, A. M. G., Raska, J., Fojtik, P., Monti, G., Lunding, M., Bartova, S., Pospisilova, V., van der Lee, S. J., Van Dongen, J., Bossaerts, L., Van Broeckhoven, C., Dols-Icardo, O., Lléo, A., Bellini, S., Ghidoni, R., Hulsman, M., Petsko, G. A., Sleegers, K., Bohaciakova, D., …, & Andersen, O. M. (2024). The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer’s disease. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2408262121

Vancouver

Jensen AMG, Raska J, Fojtik P, Monti G, Lunding M, Bartova S, et al. The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer’s disease. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2408262121

BibTeX
@article{Jensen2024,
  author = {Jensen, Anne Mette G and Raska, Jan and Fojtik, Petr and Monti, Giulia and Lunding, Melanie and Bartova, Simona and Pospisilova, Veronika and van der Lee, Sven J and Van Dongen, Jasper and Bossaerts, Liene and Van Broeckhoven, Christine and Dols-Icardo, Oriol and Lléo, Alberto and Bellini, Sonia and Ghidoni, Roberta and Hulsman, Marc and Petsko, Gregory A and Sleegers, Kristel and Bohaciakova, Dasa and Holstege, Henne and Andersen, Olav M},
  title = {The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer’s disease},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2408262121}
}
Kostenlos starten →